{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:06:51Z","timestamp":1792782411785,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Philipps-Universit\u00e4t Marburg","id":[{"id":"https:\/\/ror.org\/01rdrb571","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Merkel cell carcinoma (MCC) is a\u00a0rare malignancy with an annual incidence in Germany of 5.2\u00a0per million for men and 3.8\u00a0per million for women, predominantly affecting sun-exposed areas in older adults. Despite a\u00a0frequently unfavorable prognosis, outcomes are multifactorial and depend on tumor site, disease stage, performance status, patient age, sex, and immune competence. The current standard of care prescribes surgical resection followed by adjuvant radiotherapy of the tumor bed, ideally initiated within 8\u00a0weeks after surgery to optimize clinical outcomes. In case of lymph node involvement, lymph node dissection and\/or radiotherapy of the involved nodal basin are recommended. Furthermore, new evidence supports the effectiveness of shorter radiotherapy approaches, with moderate hypofractionated or even ultrahypofractionated schedules serving as effective options for certain patients, particularly those with frailty or comorbidities, or when it is clinically necessary to minimize the treatment burden. In cases of inoperability, refusal of surgery, or significant frailty, definitive local radiotherapy can achieve sufficient disease control. The synergistic potential of combining immunotherapy with radiation in advanced cases remains a\u00a0key area for ongoing research.<\/jats:p>","DOI":"10.1007\/s00066-026-02587-0","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:47:18Z","timestamp":1788929238000},"page":"1003-1010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-7336","authenticated-orcid":false,"given":"Khaled","family":"Elsayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Falke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Trommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gawish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyer","family":"Roohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Glowka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2587_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15292","author":"LE Hernandez","year":"2022","unstructured":"Hernandez\u00a0LE, Mohsin\u00a0N, Yaghi\u00a0M et\u00a0al (2022) Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options. Dermatologic Therapy. https:\/\/doi.org\/10.1111\/dth.15292","journal-title":"Dermatologic Therapy"},{"issue":"5","key":"2587_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102977","volume":"9","author":"I Lugowska","year":"2024","unstructured":"Lugowska\u00a0I, Becker\u00a0JC, Ascierto\u00a0PA et\u00a0al (2024) Merkel-cell carcinoma: ESMO\u2013EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 9(5):102977. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102977","journal-title":"ESMO open"},{"issue":"4","key":"2587_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40257-024-00858-z","volume":"25","author":"JC Becker","year":"2024","unstructured":"Becker\u00a0JC, Stang\u00a0A, Schrama\u00a0D et\u00a0al (2024) Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates. Am J Clin Dermatol 25(4):541\u2013557. https:\/\/doi.org\/10.1007\/s40257-024-00858-z","journal-title":"Am J Clin Dermatol"},{"key":"2587_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.02.003","volume":"94","author":"A Stang","year":"2018","unstructured":"Stang\u00a0A, Becker\u00a0JC, Nghiem\u00a0P et\u00a0al (2018) The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment. Eur J Cancer 94:47\u201360. https:\/\/doi.org\/10.1016\/j.ejca.2018.02.003","journal-title":"European Journal of Cancer"},{"issue":"11","key":"2587_CR5","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.jid.2021.04.007","volume":"141","author":"CM Olsen","year":"2021","unstructured":"Olsen\u00a0CM, Pandeya\u00a0N, Whiteman\u00a0DC (2021) International Increases in Merkel Cell Carcinoma Incidence Rates between 1997 and 2016. J\u00a0Invest Dermatol 141(11):2596\u20132601.e1. https:\/\/doi.org\/10.1016\/j.jid.2021.04.007","journal-title":"Journal of Investigative Dermatology"},{"issue":"11","key":"2587_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112158","volume":"16","author":"A Stang","year":"2024","unstructured":"Stang\u00a0A, M\u00f6ller\u00a0L, Wellmann\u00a0I et\u00a0al (2024) Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008\u20132021. Cancers 16(11):2158. https:\/\/doi.org\/10.3390\/cancers16112158","journal-title":"Cancers"},{"key":"2587_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100665","volume":"33","author":"MR Gonzalez","year":"2022","unstructured":"Gonzalez\u00a0MR, Bryce-Alberti\u00a0M, Portmann-Baracco\u00a0A et\u00a0al (2022) Treatment and survival outcomes in metastatic Merkel cell carcinoma: Analysis of 2010 patients from the SEER database. Cancer Treat Res Commun 33:100665. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100665","journal-title":"Cancer Treatment and Research Communications"},{"issue":"24","key":"2587_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246176","volume":"14","author":"S Silling","year":"2022","unstructured":"Silling\u00a0S, Kreuter\u00a0A, Gambichler\u00a0T et\u00a0al (2022) Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma. Cancers 14(24):6176. https:\/\/doi.org\/10.3390\/cancers14246176","journal-title":"Cancers"},{"key":"2587_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.77","author":"JC Becker","year":"2017","unstructured":"Becker\u00a0JC, Stang\u00a0A, DeCaprio\u00a0JA et\u00a0al (2017) Merkel cell carcinoma. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/nrdp.2017.77","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2587_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00000421-200202000-00011","volume":"25","author":"HT Eich","year":"2002","unstructured":"Eich\u00a0HT, Eich\u00a0D, Staar\u00a0S et\u00a0al (2002) Role of postoperative radiotherapy in the management of Merkel cell carcinoma. American journal of clinical oncology 25(1):50\u201356. https:\/\/doi.org\/10.1097\/00000421-200202000-00011","journal-title":"American journal of clinical oncology"},{"key":"2587_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115406","volume":"221","author":"GC Lodde","year":"2025","unstructured":"Lodde\u00a0GC, Leiter\u00a0U, Gesierich\u00a0A et\u00a0al (2025) Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients. Eur J Cancer 221:115406. https:\/\/doi.org\/10.1016\/j.ejca.2025.115406","journal-title":"European Journal of Cancer"},{"issue":"9","key":"2587_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamadermatol.2019.2068","volume":"155","author":"A Hanlon","year":"2019","unstructured":"Hanlon\u00a0A (2019) Merkel Cell Carcinoma. JAMA Dermatol 155(9):1096\u20131096. https:\/\/doi.org\/10.1001\/jamadermatol.2019.2068","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2587_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ddg.14930_g","volume":"21","author":"JC Becker","year":"2023","unstructured":"Becker\u00a0JC, Beer\u00a0AJ, DeTemple\u00a0VK et\u00a0al (2023) S2k-Leitlinie - Merkelzellkarzinom - Update 2022. J\u00a0Dtsch Dermatol Ges 21(3):305\u2013317. https:\/\/doi.org\/10.1111\/ddg.14930_g","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"},{"issue":"1","key":"2587_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00200-0","volume":"6","author":"YH Dai","year":"2021","unstructured":"Dai\u00a0YH, Wang\u00a0YF, Shen\u00a0PC et\u00a0al (2021) Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. NPJ Genom Med 6(1):40. https:\/\/doi.org\/10.1038\/s41525-021-00200-0","journal-title":"NPJ genomic medicine"},{"issue":"12","key":"2587_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41417-020-0174-y","volume":"27","author":"K Choucair","year":"2020","unstructured":"Choucair\u00a0K, Morand\u00a0S, Stanbery\u00a0L et\u00a0al (2020) TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials. Cancer gene therapy 27(12):841\u2013853. https:\/\/doi.org\/10.1038\/s41417-020-0174-y","journal-title":"Cancer gene therapy"},{"issue":"1","key":"2587_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02651-8","volume":"16","author":"S Passerini","year":"2025","unstructured":"Passerini\u00a0S, Fracella\u00a0M, Ferlosio\u00a0A et\u00a0al (2025) Investigation of mRNA expression levels of DNA damage response genes in Merkel Cell Polyomavirus-positive Merkel Cell Carcinoma: a pilot study. Discov Oncol 16(1):852. https:\/\/doi.org\/10.1007\/s12672-025-02651-8","journal-title":"Discover oncology"},{"key":"2587_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1413793","volume":"14","author":"EA Pedersen","year":"2024","unstructured":"Pedersen\u00a0EA, Verhaegen\u00a0ME, Joseph\u00a0MK et\u00a0al (2024) Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models. Front Oncol 14:1413793. https:\/\/doi.org\/10.3389\/fonc.2024.1413793","journal-title":"Frontiers in oncology"},{"issue":"7","key":"2587_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/ced.15120","volume":"47","author":"SA Moore","year":"2022","unstructured":"Moore\u00a0SA, Narayanan\u00a0D, Simonette\u00a0RA et\u00a0al (2022) Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma. Clin Exp Dermatol 47(7):1354\u20131357. https:\/\/doi.org\/10.1111\/ced.15120","journal-title":"Clinical and experimental dermatology"},{"issue":"3","key":"2587_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ijrobp.2009.05.067","volume":"77","author":"M Foote","year":"2010","unstructured":"Foote\u00a0M, Harvey\u00a0J, Porceddu\u00a0S et\u00a0al (2010) Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Adv Radiat Oncol 77(3):677\u2013684. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.05.067","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"2","key":"2587_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jaad.2023.07.1047","volume":"90","author":"NA Alexander","year":"2024","unstructured":"Alexander\u00a0NA, Schaub\u00a0SK, Goff\u00a0PH et\u00a0al (2024) Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma. J\u00a0Am Acad Dermatol 90(2):261\u2013268. https:\/\/doi.org\/10.1016\/j.jaad.2023.07.1047","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"2587_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jso.27421","volume":"128","author":"KL Ma","year":"2023","unstructured":"Ma\u00a0KL, Sharon\u00a0CE, Tortorello\u00a0GN et\u00a0al (2023) Delayed time to radiation and overall survival in Merkel cell carcinoma. J\u00a0Surg Oncol 128(8):1385\u20131393. https:\/\/doi.org\/10.1002\/jso.27421","journal-title":"Journal of Surgical Oncology"},{"issue":"9","key":"2587_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw042","volume":"108","author":"S Bhatia","year":"2016","unstructured":"Bhatia\u00a0S, Storer\u00a0BE, Iyer\u00a0JG et\u00a0al (2016) Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base. JNCI Cancer Spectr 108(9):djw042. https:\/\/doi.org\/10.1093\/jnci\/djw042","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2587_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.radonc.2019.02.015","volume":"134","author":"F Petrelli","year":"2019","unstructured":"Petrelli\u00a0F, Ghidini\u00a0A, Torchio\u00a0M et\u00a0al (2019) Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis. Clin Transl Radiat Oncol 134:211\u2013219. https:\/\/doi.org\/10.1016\/j.radonc.2019.02.015","journal-title":"Radiotherapy and Oncology"},{"key":"2587_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jss.2021.03.062","volume":"266","author":"WG Wong","year":"2021","unstructured":"Wong\u00a0WG, Stahl\u00a0K, Olecki\u00a0EJ et\u00a0al (2021) Survival Benefit of Guideline-Concordant Postoperative Radiation for Local Merkel Cell Carcinoma. Journal of Surgical Research 266:168\u2013179. https:\/\/doi.org\/10.1016\/j.jss.2021.03.062","journal-title":"Journal of Surgical Research"},{"issue":"10","key":"2587_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2176","volume":"153","author":"SA Patel","year":"2017","unstructured":"Patel\u00a0SA, Qureshi\u00a0MM, Sahni\u00a0D et\u00a0al (2017) Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection. JAMA Dermatol 153(10):1007. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2176","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2587_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2026.102029","volume":"11","author":"S Karki","year":"2026","unstructured":"Karki\u00a0S, Kersch\u00a0CN, Melson\u00a0RA et\u00a0al (2026) No Association Between Radiation Dose and Clinical Outcomes in Merkel Cell Carcinoma in the Veteran Population. Adv Radiat Oncol 11(6):102029. https:\/\/doi.org\/10.1016\/j.adro.2026.102029","journal-title":"Advances in Radiation Oncology"},{"issue":"1","key":"2587_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.suronc.2017.10.005","volume":"27","author":"JR Sims","year":"2018","unstructured":"Sims\u00a0JR, Grotz\u00a0TE, Pockaj\u00a0BA et\u00a0al (2018) Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients. Surg Oncol 27(1):11\u201317. https:\/\/doi.org\/10.1016\/j.suronc.2017.10.005","journal-title":"Surgical Oncology"},{"issue":"12","key":"2587_CR28","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1245\/s10434-021-10031-z","volume":"28","author":"RJ Straker","year":"2021","unstructured":"Straker\u00a0RJ, Carr\u00a0MJ, Sinnamon\u00a0AJ et\u00a0al (2021) Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma. Ann Surg Oncol 28(12):6995\u20137003. https:\/\/doi.org\/10.1245\/s10434-021-10031-z","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2587_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","volume":"23","author":"T Jouary","year":"2012","unstructured":"Jouary\u00a0T, Leyral\u00a0C, Dreno\u00a0B et\u00a0al (2012) Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Facts Views Vis Obgyn 23(4):1074\u20131080. https:\/\/doi.org\/10.1093\/annonc\/mdr318","journal-title":"Annals of Oncology"},{"key":"2587_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-171","author":"SH Kang","year":"2012","unstructured":"Kang\u00a0SH, Haydu\u00a0LE, Goh\u00a0RYH et\u00a0al (2012) Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717X-7-171","journal-title":"Radiat Oncol"},{"issue":"2","key":"2587_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1245\/s10434-018-7072-7","volume":"26","author":"JS Lee","year":"2019","unstructured":"Lee\u00a0JS, Durham\u00a0AB, Bichakjian\u00a0CK et\u00a0al (2019) Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma. Ann Surg Oncol 26(2):387\u2013394. https:\/\/doi.org\/10.1245\/s10434-018-7072-7","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2587_CR32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.amjsurg.2020.02.018","volume":"220","author":"JD Cramer","year":"2020","unstructured":"Cramer\u00a0JD, Suresh\u00a0K, Sridharan\u00a0S (2020) Completion lymph node dissection for merkel cell carcinoma. Am J Surg 220(4):982\u2013986. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.02.018","journal-title":"The American Journal of Surgery"},{"issue":"10357","key":"2587_CR33","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(22)01659-2","volume":"400","author":"S Kim","year":"2022","unstructured":"Kim\u00a0S, Wuthrick\u00a0E, Blakaj\u00a0D et\u00a0al (2022) Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet (London, England) 400(10357):1008\u20131019. https:\/\/doi.org\/10.1016\/S0140-6736(22)01659-2","journal-title":"Lancet (London, England)"},{"issue":"8","key":"2587_CR34","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cam4.458","volume":"4","author":"JG Iyer","year":"2015","unstructured":"Iyer\u00a0JG, Parvathaneni\u00a0U, Gooley\u00a0T et\u00a0al (2015) Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma. Cancer Med 4(8):1161\u20131170. https:\/\/doi.org\/10.1002\/cam4.458","journal-title":"Cancer Medicine"},{"key":"2587_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2022.05.012","volume":"173","author":"KX Liu","year":"2022","unstructured":"Liu\u00a0KX, Milligan\u00a0MG, Schoenfeld\u00a0JD et\u00a0al (2022) Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage\u00a0I-III curatively-treated Merkel cell carcinoma. Clin Transl Radiat Oncol 173:32\u201340. https:\/\/doi.org\/10.1016\/j.radonc.2022.05.012","journal-title":"Radiotherapy and Oncology"},{"key":"2587_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02516-4","author":"L Gonzalez","year":"2024","unstructured":"Gonzalez\u00a0L, Rubens\u00a0M, Yarlagadda\u00a0S et\u00a0al (2024) Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-024-02516-4","journal-title":"Radiat Oncol"},{"issue":"6","key":"2587_CR37","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.adro.2020.07.003","volume":"5","author":"MM Cook","year":"2020","unstructured":"Cook\u00a0MM, Schaub\u00a0SK, Goff\u00a0PH et\u00a0al (2020) Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck. Adv Radiat Oncol 5(6):1248\u20131254. https:\/\/doi.org\/10.1016\/j.adro.2020.07.003","journal-title":"Advances in Radiation Oncology"},{"issue":"6","key":"2587_CR38","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jaad.2025.01.099","volume":"92","author":"M Dykstra","year":"2025","unstructured":"Dykstra\u00a0M, Parra\u00a0CE, Hayman\u00a0JA et\u00a0al (2025) Adjuvant single-fraction radiotherapy to the resected primary tumor site and stage IIIA regional disease results in high locoregional control in Merkel cell carcinoma in a\u00a0single-institution retrospective study. J\u00a0Am Acad Dermatol 92(6):1438\u20131439. https:\/\/doi.org\/10.1016\/j.jaad.2025.01.099","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"2587_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.387","volume":"96","author":"N Cimbak","year":"2016","unstructured":"Cimbak\u00a0N, Barker\u00a0CA (2016) Short-Course Radiation Therapy for Merkel Cell Carcinoma: Relative Effectiveness in a\u00a0\u201cRadiosensitive\u201d Tumor. Adv Radiat Oncol 96(2):S160. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.06.387","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"6","key":"2587_CR40","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jaad.2012.03.018","volume":"67","author":"MB Colgan","year":"2012","unstructured":"Colgan\u00a0MB, Tarantola\u00a0TI, Weaver\u00a0AL et\u00a0al (2012) The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J\u00a0Am Acad Dermatol 67(6):1250\u20131256. https:\/\/doi.org\/10.1016\/j.jaad.2012.03.018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"2587_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2009.06.021","volume":"62","author":"R Concannon","year":"2010","unstructured":"Concannon\u00a0R, Larcos\u00a0GS, Veness\u00a0M (2010) The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia. J\u00a0Am Acad Dermatol 62(1):76\u201384. https:\/\/doi.org\/10.1016\/j.jaad.2009.06.021","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"2587_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/1754-9485.12705","volume":"62","author":"M Poulsen","year":"2018","unstructured":"Poulsen\u00a0M, Macfarlane\u00a0D, Veness\u00a0M et\u00a0al (2018) Prospective analysis of the utility of 18- FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03. J\u00a0Med Imaging Radiat Oncol 62(3):412\u2013419. https:\/\/doi.org\/10.1111\/1754-9485.12705","journal-title":"J Med Imag Rad Onc"},{"issue":"9","key":"2587_CR43","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2967\/jnumed.115.158261","volume":"56","author":"K Byrne","year":"2015","unstructured":"Byrne\u00a0K, Siva\u00a0S, Chait\u00a0L et\u00a0al (2015) 15-Year Experience of 18\u202fF-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma. J\u00a0Nucl Med 56(9):1328\u20131333. https:\/\/doi.org\/10.2967\/jnumed.115.158261","journal-title":"J Nucl Med"},{"issue":"1","key":"2587_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaad.2017.02.015","volume":"77","author":"DA Gunaratne","year":"2017","unstructured":"Gunaratne\u00a0DA, Howle\u00a0JR, Veness\u00a0MJ (2017) Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: A review and analysis of the literature. J\u00a0Am Acad Dermatol 77(1):142\u2013148.e1. https:\/\/doi.org\/10.1016\/j.jaad.2017.02.015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"2587_CR45","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/archderm.139.12.1587","volume":"139","author":"L Mortier","year":"2003","unstructured":"Mortier\u00a0L (2003) Radiotherapy Alone for Primary Merkel Cell Carcinoma. Arch Dermatol 139(12):1587. https:\/\/doi.org\/10.1001\/archderm.139.12.1587","journal-title":"Arch Dermatol"},{"issue":"5","key":"2587_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jaad.2010.07.043","volume":"65","author":"E Pape","year":"2011","unstructured":"Pape\u00a0E, Rezvoy\u00a0N, Penel\u00a0N et\u00a0al (2011) Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients. J\u00a0Am Acad Dermatol 65(5):983\u2013990. https:\/\/doi.org\/10.1016\/j.jaad.2010.07.043","journal-title":"Journal of the American Academy of Dermatology"},{"key":"2587_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01815-4","author":"M Dubois","year":"2021","unstructured":"Dubois\u00a0M, Abi Rached\u00a0H, Escande\u00a0A et\u00a0al (2021) Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-021-01815-4","journal-title":"Radiat Oncol"},{"key":"2587_CR48","doi-asserted-by":"publisher","DOI":"10.3310\/EEWD6684","author":"NM Steven","year":"2025","unstructured":"Steven\u00a0NM, Pirrie\u00a0S, Jefferson-Hulme\u00a0Y et\u00a0al (2025) Rational treatment selection for primary Merkel Cell Carcinoma: a Rational MCC RCT comparing surgery and radiotherapy with parallel observational study. Efficacy Mech Eval. https:\/\/doi.org\/10.3310\/EEWD6684","journal-title":"Efficacy Mech Eval"},{"issue":"19","key":"2587_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193272","volume":"17","author":"P Tai","year":"2025","unstructured":"Tai\u00a0P, Alqaisi\u00a0O, Al-Ghabeesh\u00a0S et\u00a0al (2025) Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review. Cancers 17(19):3272. https:\/\/doi.org\/10.3390\/cancers17193272","journal-title":"Cancers"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02587-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:44:31Z","timestamp":1790070271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02587-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2587"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02587-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Elsayad, I.\u00a0Falke, M.\u00a0Trommer, T.\u00a0Jost, A.\u00a0R\u00fchle, A.\u00a0Gawish, S.\u00a0Roohani, A.\u00a0Glowka, M.\u00a0Hecht, E.\u00a0Gkika, K.\u00a0Hering, L.\u00a0K\u00f6nig, S.\u00a0Corradini, H.T.\u00a0Eich, and D.\u00a0Vordermark declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":2,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}